Dysphagia News and Research

RSS

Dysphagia is the medical term for the symptom of difficulty in swallowing. Although classified under "symptoms and signs" in ICD-10, the term is sometimes used as a condition in its own right. Sufferers are sometimes unaware of their dysphagia.

New information on pathogenesis of feeding and swallowing difficulties in kids with autism

Collaborative research out of the George Washington University (GW) reveals new information on the pathogenesis of feeding and swallowing difficulties often found in children with neurodevelopmental disorders, including autism and intellectual disability.

20 Feb 2014

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Ipsen today announced positive initial results from the double-blind phase III study of Dysport (abobotulinumtoxinA) in Adult Upper Limb spasticity. Regarding the primary endpoints, treatment with Dysport showed statistically significant response versus placebo in the improvement of muscle tone, as measured by the Modified Ashworth Scale.

17 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Cancer detection programme using PENTAX Medical equipment achieves remarkable results

PENTAX Medical equipment has been used to set up a pioneering head and neck cancer detection programme at a hospital Trust in Coventry, which has achieved remarkable results; reduced the length of time the patient stays in hospital and reduced costs.

From PENTAX Medical Company 8 Nov 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

Swallow therapy combats post-radiotherapy dysphagia

Swallowing exercises can help to minimize the risk for dysphagia in patients undergoing radiotherapy for head and neck cancer, a case study suggests.

20 Sep 2013

Head and neck cancer patients receiving radiation benefit from swallowing exercises

A study at UCLA's Jonsson Comprehensive Cancer Center has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to need a feeding tube or suffer unwanted side effects such as worsening of diet or narrowing of the throat passage if they performed a set of prescribed swallowing exercises - called a "swallow preservation protocol" - during therapy.

5 Sep 2013

Head, neck cancer patients receiving radiation complied with SPP likely to suffer side effects

A study from UCLA's Jonsson Comprehensive Cancer Center (JCCC) has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to suffer unwanted side effects such as worsening of diet, need for a feeding tube, or narrowing of the throat passage if they complied with a set of prescribed swallowing exercises called a swallow preservation protocol (SPP) during therapy.

30 Aug 2013

New treatment guidelines on diagnosis and management of achalasia

New treatment guidelines on the diagnosis and management of achalasia, a primary motor disorder of the esophagus, appear in the August issue of The American Journal of Gastroenterology.

24 Jul 2013

New online resource provides practical guidance on caring for patients with dysphagia

Healthcare professionals caring for patients with dysphagia (swallowing difficulties) now have access to a new and comprehensive online resource called 'Medicines Optimisation in Patients with Dysphagia'.

2 May 2013

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a research study, conducted with an independent market research firm, that identified a significant unmet medical need for improved treatments for patients with chronic pain and dysphagia/odynophagia. In clinical practice, dysphagia is most often defined as difficulty in swallowing and odynophagia is defined as pain upon swallowing.

22 Apr 2013

Novel sensor improves success rate in diagnosing dysphagia

Those suffering from swallowing difficulties, especially stroke patients, could be evaluated more efficiently and noninvasively thanks to research under way at the University of Pittsburgh and the University of Toronto.

27 Mar 2013

Medication use and doctor visits drive up jaw necrosis-related costs

Long-term medication use and follow-up visits are the main drivers affecting costs associated with cancer-related bisphosphonate-associated osteonecrosis of the jaw, report researchers in Oral Diseases.

8 Mar 2013

Left-sided brain injury increases infection risk

Patients with a left-sided brain injury are more likely to develop hospital-acquired infections than those with right-sided injury, show study findings.

5 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Jones & Bartlett Learning publishes 'Introduction to Neurogenic Communication Disorders'

M. Hunter Manasco, Ph.D., C.C.C.-S.L.P., assistant professor of speech-language pathology at Misericordia University, has had the textbook and video combination, "Introduction to Neurogenic Communication Disorders,'' published by Jones & Bartlett Learning.

28 Feb 2013

Dysphagia News and Research

Further Reading

New information on pathogenesis of feeding and swallowing difficulties in kids with autism

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Cancer detection programme using PENTAX Medical equipment achieves remarkable results

Bayer HealthCare receives FDA approval for Adempas tablets

Swallow therapy combats post-radiotherapy dysphagia

Head and neck cancer patients receiving radiation benefit from swallowing exercises

Head, neck cancer patients receiving radiation complied with SPP likely to suffer side effects

New treatment guidelines on diagnosis and management of achalasia

New online resource provides practical guidance on caring for patients with dysphagia

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Novel sensor improves success rate in diagnosing dysphagia

Medication use and doctor visits drive up jaw necrosis-related costs

Left-sided brain injury increases infection risk

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Jones & Bartlett Learning publishes 'Introduction to Neurogenic Communication Disorders'

Bracelet-like device with magnetic beads can control gastroesophageal reflux disease

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Elemental diet may help adults with eosinophilic esophagitis

Medical cannabis can improve appetite, ease chronic pain, say researchers

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News